{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:44:20Z","timestamp":1795031060823,"version":"4.10.2"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011797","name":"Turun Yliopistollinen Keskussairaala","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010600","name":"Tays","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010600","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.lanepe.2021.100049","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T01:38:40Z","timestamp":1611884320000},"page":"100049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7124-3515","authenticated-orcid":false,"given":"Pia","family":"Osterlund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5899-0233","authenticated-orcid":false,"given":"Tapio","family":"Salminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena-Maija","family":"Soveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raija","family":"Kallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmo","family":"Kellokumpu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamarja","family":"Lamminm\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Halonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raija","family":"Ristam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eila","family":"Lantto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-5894","authenticated-orcid":false,"given":"Aki","family":"Uutela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerik","family":"Osterlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-7838","authenticated-orcid":false,"given":"Ali","family":"Ovissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eetu","family":"Heerv\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Lehtom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"R\u00e4s\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Murashev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Aroviita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Jekunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9631-6082","authenticated-orcid":false,"given":"Rene\u00e9","family":"Lindvall-Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nyandoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Kononen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lepist\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"Poussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Muhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"\u00c5lgars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Isoniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lanepe.2021.100049_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.lanepe.2021.100049_bib0002","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/annonc\/mdm267","article-title":"Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification","volume":"18","author":"Sorbye","year":"2007","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100049_bib0003","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000454687","article-title":"Pattern and dynamics of distant metastases in metastatic colorectal cancer","volume":"33","author":"Holch","year":"2017","journal-title":"Visceral Med"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100049_bib0004","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100049_bib0005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/bjs5.50299","article-title":"Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study","volume":"4","author":"Vayrynen","year":"2020","journal-title":"BJS Open"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100049_bib0006","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cam4.2673","article-title":"Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100049_bib0007","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.canep.2015.07.009","article-title":"Metastatic spread pattern after curative colorectal cancer surgery. A retrospective, longitudinal analysis","volume":"39","author":"Augestad","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"9","key":"10.1016\/j.lanepe.2021.100049_bib0008","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1067\/j.cpsurg.2018.08.004","article-title":"Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?","volume":"55","author":"Stewart","year":"2018","journal-title":"Curr Probl Surg"},{"issue":"8","key":"10.1016\/j.lanepe.2021.100049_bib0009","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lanepe.2021.100049_bib0010","article-title":"NCCN guidelines for rectal cancer","author":"Benson","year":"2020","journal-title":"Natl Compr Cancer Netw Guidel"},{"key":"10.1016\/j.lanepe.2021.100049_bib0011","article-title":"NCCN guidelines for colon cancer","author":"Benson","year":"2020","journal-title":"Natl Compr Cancer Netw Guidel"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100049_bib0012","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdx738","article-title":"Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS","volume":"29","author":"Yoshino","year":"2018","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.lanepe.2021.100049_bib0013","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1470-2045(14)70330-4","article-title":"FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial","volume":"15","author":"Heinemann","year":"2014","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.lanepe.2021.100049_bib0014","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.2017.7105","article-title":"Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial","volume":"317","author":"Venook","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100049_bib0015","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/SLA.0000000000003534","article-title":"Variation in the use of resection for colorectal cancer liver metastases","volume":"270","author":"Fenton","year":"2019","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100049_bib0016","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","article-title":"Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases","volume":"32","author":"van der Geest","year":"2015","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100049_bib0017","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12885-020-6710-1","article-title":"Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases","volume":"20","author":"Siebenh\u00fcner","year":"2020","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.lanepe.2021.100049_bib0018","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ijc.33200","article-title":"Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real-life data","volume":"148","author":"Hamers","year":"2021","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.lanepe.2021.100049_bib0019","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bjs.11609","article-title":"Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance","volume":"107","author":"Mohamed","year":"2020","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100049_bib0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(09)70330-4","article-title":"Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial","volume":"11","author":"Folprecht","year":"2010","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100049_bib0021","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1503\/cjs.014616","article-title":"Assessing resectability of colorectal liver metastases: how do different subspecialties interpret the same data?","volume":"61","author":"Aubin","year":"2018","journal-title":"Can J Surg"},{"key":"10.1016\/j.lanepe.2021.100049_bib0022","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2017.10.028","article-title":"Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3","volume":"88","author":"Modest","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lanepe.2021.100049_bib0023","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejca.2018.05.010","article-title":"Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: supported by the ARCAD Group","volume":"100","author":"Goey","year":"2018","journal-title":"Eur J Cancer"},{"issue":"23","key":"10.1016\/j.lanepe.2021.100049_bib0024","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of guarantee-time bias","volume":"31","author":"Giobbie-Hurder","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lanepe.2021.100049_bib0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/1471-2407-11-438","article-title":"Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival","volume":"11","author":"Birgisson","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100049_bib0026","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s13063-019-3837-y","article-title":"Pulmonary metastasectomy versus continued active monitoring in colorectal cancer (PulMiCC): a multicentre randomised clinical trial","volume":"20","author":"Treasure","year":"2019","journal-title":"Trials"},{"issue":"10","key":"10.1016\/j.lanepe.2021.100049_bib0027","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/codi.15113","article-title":"Pulmonary metastasectomy in colorectal cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed","volume":"22","author":"Milosevic","year":"2020","journal-title":"Colorectal Dis"},{"issue":"9","key":"10.1016\/j.lanepe.2021.100049_bib0028","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/bjs.8835","article-title":"Effect of specialist decision-making on treatment strategies for colorectal liver metastases","volume":"99","author":"Jones","year":"2012","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100049_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2019.08.1445","article-title":"Outcomes of resectability assessment of the Dutch colorectal cancer group liver metastases expert panel","volume":"229","author":"Huiskens","year":"2019","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.lanepe.2021.100049_bib0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejca.2018.07.012","article-title":"The value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancer","volume":"103","author":"Gootjes","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lanepe.2021.100049_bib0031","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.suronc.2020.02.008","article-title":"Debulking surgery for colorectal liver metastases: foolish or chance?","volume":"33","author":"Adam","year":"2020","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100049_bib0032","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.lanepe.2021.100049_bib0033","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12957-016-0807-7","article-title":"Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases","volume":"14","author":"Kawamura","year":"2016","journal-title":"W J Surg Oncol"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100049_bib0034","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/DCR.0000000000001311","article-title":"Role of repeat resection in patients with metastatic colorectal cancer: a multicenter retrospective study","volume":"62","author":"Matsumoto","year":"2019","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"10.1016\/j.lanepe.2021.100049_bib0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/bjs.8667","article-title":"Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases","volume":"99","author":"Jones","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.lanepe.2021.100049_bib0036","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/727095","article-title":"Aggressive treatment of patients with metastatic colorectal cancer increases survival: a scandinavian single-center experience","volume":"2013","author":"Brudvik","year":"2013","journal-title":"HPB Surg"},{"issue":"9","key":"10.1016\/j.lanepe.2021.100049_bib0037","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1245\/s10434-012-2382-7","article-title":"Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases","volume":"19","author":"Vigano","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.lanepe.2021.100049_bib0038","article-title":"Centralization of liver cancer surgery and impact on multidisciplinary teams working on stage IV colorectal cancer","volume":"11","author":"Weledji","year":"2017","journal-title":"Oncol Rev"},{"issue":"20","key":"10.1016\/j.lanepe.2021.100049_bib0039","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1002\/cncr.24527","article-title":"Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients","volume":"115","author":"Sorbye","year":"2009","journal-title":"Cancer"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776221000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776221000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:44:20Z","timestamp":1763009060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776221000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":39,"alternative-id":["S2666776221000260"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2021.100049","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2021.100049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100049"}}